haloperidol has been researched along with Memory Disorders in 30 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Memory Disorders: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this article was to report a case of chorea that developed in an elderly man being treated with gabapentin for severe anxiety." | 7.75 | Chorea associated with gabapentin use in an elderly man. ( Attupurath, R; Aziz, R; Muralee, S; Tampi, RR; Wollman, D, 2009) |
| "307 schizophrenia subjects in their first episode of illness were recruited to participate in a clinical trial comparing the long-term efficacy of haloperidol and risperidone." | 5.11 | Correlates of cognitive deficits in first episode schizophrenia. ( Csernansky, JG; DeLisi, LE; Heydebrand, G; Hoff, AL; Rabinowitz, J; Weiser, M, 2004) |
| " phencyclidine (PCP), produces prolonged impairment of novel object recognition (NOR), suggesting they constitute a hypoglutamate-based model of cognitive impairment in schizophrenia (CIS)." | 3.81 | Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats. ( Horiguchi, M; Meltzer, HY; Miyauchi, M; Oyamada, Y; Rajagopal, L, 2015) |
| "The purpose of this article was to report a case of chorea that developed in an elderly man being treated with gabapentin for severe anxiety." | 3.75 | Chorea associated with gabapentin use in an elderly man. ( Attupurath, R; Aziz, R; Muralee, S; Tampi, RR; Wollman, D, 2009) |
| " Phencyclidine (PCP), a non-competitive NMDA-receptor antagonist, is able to induce schizophrenia-like symptoms in animals and in humans." | 3.70 | Neuroleptics ameliorate phencyclidine-induced impairments of short-term memory. ( Sabel, BA; Schroeder, H; Schroeder, U; Schwegler, H, 2000) |
| "Haloperidol-induced increase in malondialdehyde and nitrite generation as well as deficits in antioxidant enzymes activities were attenuated by chronic administration of vinpocetine." | 1.56 | Vinpocetine prevents haloperidol-induced cognitive and working memory deficits through attenuation of oxidative and nitrosative stress in mice. ( Adeyemi, OO; Isaac, AI; Ishola, IO, 2020) |
| "The aim of study was to investigate the effects of pyrroloquinoline quinone (PQQ) combined with d-serine on the modulation of glycine sites in the brain of rats using social recognition test." | 1.43 | Modulation of glycine sites enhances social memory in rats using PQQ combined with d-serine. ( Liu, D; Mao, S; Peng, Y; Qin, X; Zhang, R; Zhou, X, 2016) |
| "Haloperidol (HAL) is an antipsychotic drug that has high affinities to the dopamine D(2), but low affinities to D(1) receptors in the brain." | 1.38 | Chronic haloperidol-induced spatial memory deficits accompany the upregulation of D(1) and D(2) receptors in the caudate putamen of C57BL/6 mouse. ( Rose, GM; Xu, H; Yang, HJ, 2012) |
| "Although chronic use of methamphetamine (METH) leads to long-lasting cognitive dysfunction in humans, there are few reports about an animal model that reflects METH-induced impairment of working memory." | 1.34 | Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol. ( Dohniwa, M; Ibi, D; Kamei, H; Mizoguchi, H; Nabeshima, T; Nagai, T; Takuma, K; Yamada, K, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.33) | 18.7374 |
| 1990's | 5 (16.67) | 18.2507 |
| 2000's | 13 (43.33) | 29.6817 |
| 2010's | 10 (33.33) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ishola, IO | 1 |
| Isaac, AI | 1 |
| Adeyemi, OO | 1 |
| Onaolapo, OJ | 1 |
| Paul, TB | 1 |
| Onaolapo, AY | 1 |
| Aoyama, Y | 1 |
| Mouri, A | 1 |
| Toriumi, K | 1 |
| Koseki, T | 1 |
| Narusawa, S | 1 |
| Ikawa, N | 1 |
| Mamiya, T | 1 |
| Nagai, T | 3 |
| Yamada, K | 4 |
| Nabeshima, T | 5 |
| França, AS | 2 |
| do Nascimento, GC | 1 |
| Lopes-dos-Santos, V | 1 |
| Muratori, L | 2 |
| Ribeiro, S | 2 |
| Lobão-Soares, B | 2 |
| Tort, AB | 1 |
| Oyamada, Y | 1 |
| Horiguchi, M | 1 |
| Rajagopal, L | 1 |
| Miyauchi, M | 1 |
| Meltzer, HY | 1 |
| Nascimento, GC | 1 |
| Pereira, CM | 1 |
| Zhou, X | 1 |
| Liu, D | 1 |
| Zhang, R | 1 |
| Peng, Y | 1 |
| Qin, X | 1 |
| Mao, S | 1 |
| Rajput, SK | 1 |
| Sharma, AK | 1 |
| Meena, CL | 1 |
| Pant, AB | 1 |
| Jain, R | 1 |
| Sharma, SS | 1 |
| Murai, R | 1 |
| Matsui, K | 1 |
| Kamei, H | 2 |
| Noda, Y | 3 |
| Furukawa, H | 1 |
| Barcelos, RC | 1 |
| Benvegnú, DM | 1 |
| Boufleur, N | 1 |
| Reckziegel, P | 1 |
| Müller, LG | 1 |
| Pase, C | 1 |
| Emanuelli, T | 1 |
| Bürger, ME | 2 |
| Attupurath, R | 1 |
| Aziz, R | 1 |
| Wollman, D | 1 |
| Muralee, S | 1 |
| Tampi, RR | 1 |
| López-Téllez, JF | 1 |
| López-Aranda, MF | 1 |
| Navarro-Lobato, I | 1 |
| Masmudi-Martín, M | 1 |
| Montañez, EM | 1 |
| Calvo, EB | 1 |
| Khan, ZU | 1 |
| Xu, H | 1 |
| Yang, HJ | 1 |
| Rose, GM | 1 |
| Dietl, T | 1 |
| Herr, A | 1 |
| Brunner, H | 1 |
| Friess, E | 1 |
| Heydebrand, G | 1 |
| Weiser, M | 1 |
| Rabinowitz, J | 1 |
| Hoff, AL | 1 |
| DeLisi, LE | 1 |
| Csernansky, JG | 1 |
| Wezenberg, E | 1 |
| Sabbe, BG | 1 |
| Hulstijn, W | 1 |
| Ruigt, GS | 1 |
| Verkes, RJ | 1 |
| Morice, E | 1 |
| Billard, JM | 1 |
| Denis, C | 1 |
| Mathieu, F | 1 |
| Betancur, C | 1 |
| Epelbaum, J | 1 |
| Giros, B | 1 |
| Nosten-Bertrand, M | 1 |
| Takuma, K | 2 |
| Dohniwa, M | 1 |
| Ibi, D | 2 |
| Mizoguchi, H | 2 |
| Mihara, T | 1 |
| Mihara, K | 1 |
| Yarimizu, J | 1 |
| Mitani, Y | 1 |
| Matsuda, R | 1 |
| Yamamoto, H | 1 |
| Aoki, S | 1 |
| Akahane, A | 1 |
| Iwashita, A | 1 |
| Matsuoka, N | 1 |
| Fukakusa, A | 1 |
| Ito, Y | 1 |
| Nakatani, A | 1 |
| Kim, HC | 1 |
| Terry, AV | 1 |
| Gearhart, DA | 1 |
| Warner, S | 1 |
| Hohnadel, EJ | 1 |
| Middlemore, ML | 1 |
| Zhang, G | 1 |
| Bartlett, MG | 1 |
| Mahadik, SP | 1 |
| Colpo, G | 1 |
| Trevisol, F | 1 |
| Teixeira, AM | 1 |
| Fachinetto, R | 1 |
| Pereira, RP | 1 |
| Athayde, ML | 1 |
| Rocha, JB | 1 |
| Egashira, N | 1 |
| Ishigami, N | 1 |
| Mishima, K | 1 |
| Iwasaki, K | 1 |
| Oishi, R | 1 |
| Fujiwara, M | 1 |
| Maurice, T | 2 |
| Junien, JL | 1 |
| Privat, A | 2 |
| Tang, YP | 1 |
| Gilbertson, MW | 1 |
| van Kammen, DP | 1 |
| Phan, VL | 1 |
| Schroeder, U | 1 |
| Schroeder, H | 1 |
| Schwegler, H | 1 |
| Sabel, BA | 1 |
| Lazarova-Bakarova, MB | 1 |
| Petkova, BP | 1 |
| Todorov, IK | 1 |
| Petkov, VD | 1 |
| Siegel, GJ | 1 |
| Mones, RJ | 1 |
3 trials available for haloperidol and Memory Disorders
| Article | Year |
|---|---|
Correlates of cognitive deficits in first episode schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Cognition Disorders; Diagnostic and Statistical Manual of M | 2004 |
The role of sedation tests in identifying sedative drug effects in healthy volunteers and their power to dissociate sedative-related impairments from memory dysfunctions.
Topics: Adult; Affect; Antipsychotic Agents; Arousal; Benzodiazepines; Choice Behavior; Cross-Over Studies; | 2007 |
Recent and remote memory dissociation: medication effects and hippocampal function in schizophrenia.
Topics: Adult; Antipsychotic Agents; Attention; Double-Blind Method; Haloperidol; Hippocampus; Humans; Male; | 1997 |
27 other studies available for haloperidol and Memory Disorders
| Article | Year |
|---|---|
Vinpocetine prevents haloperidol-induced cognitive and working memory deficits through attenuation of oxidative and nitrosative stress in mice.
Topics: Animals; Cognition; Haloperidol; Memory Disorders; Memory, Short-Term; Mice; Nitrosative Stress; Oxi | 2020 |
Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Anxiety; Behavior, Animal; Benzodiazepines; Do | 2017 |
Clozapine ameliorates epigenetic and behavioral abnormalities induced by phencyclidine through activation of dopamine D1 receptor.
Topics: Animals; Antipsychotic Agents; Benzazepines; Butyric Acid; Calcium-Calmodulin-Dependent Protein Kina | 2014 |
Beta2 oscillations (23-30 Hz) in the mouse hippocampus during novel object recognition.
Topics: Animals; Beta Rhythm; Electrodes, Implanted; Exploratory Behavior; Haloperidol; Hippocampus; Memory | 2014 |
Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Haloperidol | 2015 |
Object recognition impairment and rescue by a dopamine D2 antagonist in hyperdopaminergic mice.
Topics: Animals; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationsh | 2016 |
Modulation of glycine sites enhances social memory in rats using PQQ combined with d-serine.
Topics: Animals; Antipsychotic Agents; Clozapine; Dizocilpine Maleate; Drug Contamination; Drug Synergism; G | 2016 |
Effect of L-pGlu-(1-benzyl)-l-His-l-Pro-NH
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Ischemia; Catalepsy; Cell Death; Diseas | 2016 |
Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; | 2009 |
Effects of omega-3 essential fatty acids (omega-3 EFAs) on motor disorders and memory dysfunction typical neuroleptic-induced: behavioral and biochemical parameter.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Disease Models, An | 2010 |
Chorea associated with gabapentin use in an elderly man.
Topics: Aged; Amines; Analgesics; Anti-Dyskinesia Agents; Anxiety; Chorea; Cognition Disorders; Cyclohexanec | 2009 |
Prefrontal inositol triphosphate is molecular correlate of working memory in nonhuman primates.
Topics: Amphetamine; Animals; Antipsychotic Agents; Calcium; Calcium Signaling; Central Nervous System Stimu | 2010 |
Chronic haloperidol-induced spatial memory deficits accompany the upregulation of D(1) and D(2) receptors in the caudate putamen of C57BL/6 mouse.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Blotting, Western; Brain; Caudate Nucleus; Dose-Res | 2012 |
Capgras syndrome--out of sight, out of mind?
Topics: Antipsychotic Agents; Brain; Capgras Syndrome; Female; Haloperidol; Humans; Memory Disorders; Middle | 2003 |
Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia.
Topics: Animals; Brain Diseases, Metabolic; Cognition Disorders; Disease Models, Animal; Dopamine; Dopamine | 2007 |
Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Blotting, Western; Central Nervous System Stimu | 2007 |
Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Aminopyridines; Ani | 2007 |
Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice.
Topics: Animals; Behavior, Animal; Clozapine; Dose-Response Relationship, Drug; Exploratory Behavior; Halope | 2008 |
Protracted effects of chronic oral haloperidol and risperidone on nerve growth factor, cholinergic neurons, and spatial reference learning in rats.
Topics: Acetylcholine; Administration, Oral; Animals; Antipsychotic Agents; Basal Nucleus of Meynert; Brain; | 2007 |
Ilex paraguariensis has antioxidant potential and attenuates haloperidol-induced orofacial dyskinesia and memory dysfunction in rats.
Topics: Animals; Antioxidants; Behavior, Animal; Haloperidol; Ilex paraguariensis; In Vitro Techniques; Male | 2007 |
Delta9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Cognition Disorders | 2008 |
Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via sigma 1-receptors.
Topics: Animals; Anti-Anxiety Agents; Avoidance Learning; Dehydroepiandrosterone Sulfate; Dizocilpine Maleat | 1997 |
Involvement of activation of dopaminergic neuronal system in learning and memory deficits associated with experimental mild traumatic brain injury.
Topics: Animals; Apomorphine; Benzazepines; Brain Injuries; Dopamine; Dopamine Agonists; Dopamine Antagonist | 1997 |
The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma (sigma) receptor ligands involves both sigma1 and sigma2 sites.
Topics: Amnesia; Animals; Anticonvulsants; Avoidance Learning; Carbon Monoxide; Ethylamines; Guanidines; Hal | 1999 |
Neuroleptics ameliorate phencyclidine-induced impairments of short-term memory.
Topics: Animals; Antipsychotic Agents; Benzazepines; Brain; Excitatory Amino Acid Antagonists; Glutamic Acid | 2000 |
Memory impairment induced by combined disturbance of noradrenergic and dopaminergic neurotransmissions: effects of nootropic drugs.
Topics: Animals; Avoidance Learning; Benzoates; Central Nervous System Agents; Clonidine; Dopamine; Haloperi | 1991 |
Modification of choreiform activity by Haloperidol.
Topics: Administration, Oral; Chorea; Chronic Disease; Electrocardiography; Female; Haloperidol; Humans; Mem | 1971 |